EMA Reflection Paper provides Concrete Information about Risk based Quality Management
In the GMP News from 28 September 2011
we announced the publication of EMA's "Reflection paper on risk based quality management in clinical trials". The 31-page document is a draft to be commented. It gets very interesting from page 14 on which presents an Annex 1 entitled "Points to consider when establishing a risk based quality management approach". Annex 1 is composed of a table which shows the points to consider for the risk identification and examples of how to control them and eventually mitigation and/or acceptance solutions. Clinical studies are - of course - a focus. However, the table is also interesting for other fields - e.g. following risks are discussed:- Contract issues
- Project Management
- Personnel Qualification
- Quality Control Documentation
- Deviations
- GMP Compliance
Conclusion: Although the focus is on clinical studies, it is interesting to read about EMA's specific positions regarding risk control. The question is what the final document will look like? Now, it is already clear that risk based quality management will play a more significant role.
Author:
Sven Pommeranz
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
25.06.2025Is Knowledge Management a Part of the Pharmaceutical Quality System?
11.06.2025Swissmedic differentiates GMP Scope for Manufacturing and Preparation for Administration
28.05.2025A View on the EU Critical Medicines Act to secure Pharma Supply Chains
20.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review